MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a other report with the FDA on 2020-03-30 for UNKNOWN TRAPEASE 466P306X manufactured by Cordis Corporation.
[188518673]
As reported, a patient underwent placement of a trapease inferior vena cava (ivc) filter. The indication for filter placement is not available. The filter subsequently malfunctioned and caused injury and damage to the patient, including, but not limited to, tilting of the filter. The filter remains implanted; thus, unavailable for analysis. The product was not returned for analysis and the sterile lot number has not been provided; therefore, no device analysis nor device history record review could be performed. The trapease vena cava filter is indicated for use in the prevention of recurrent pulmonary embolism (pe) via percutaneous placement in the vena cava for patients in which anticoagulants are contraindicated, anticoagulant therapy for thromboembolic disease has failed, emergency treatment following massive pulmonary embolism where anticipated benefits of conventional therapy are reduced or for chronic, recurrent pulmonary embolism where anticoagulant therapy has failed, or is contraindicated. The purpose of a vena cava filter is to catch thrombus from the lower extremities as it travels along normal blood flow patterns up towards the heart. Without procedural films for review, the filter tilt reported could not be confirmed. Additionally, the timing and mechanism of the filter tilt is unknown. Ivc filter tilt has been associated with the anatomy of the vessel, specifically asymmetry and tortuousness. Clinical factors that may have influenced the event include patient, lesion characteristics. Without procedural films or images for review the reported event(s) could not be confirmed. Given the limited information available for review at this time, there is nothing to suggest that the reported events are related to the design and manufacturing process of the device; therefore, no corrective action will be taken. Should additional information become available, the file will be updated accordingly.
Patient Sequence No: 1, Text Type: N, H10
[188518674]
As reported in the legal brief, a patient underwent placement of a trapease vena cava filter. The filter subsequently malfunctioned and caused injury and damage to the patient, including, but not limited to, tilting of the filter.
Patient Sequence No: 1, Text Type: D, B5
Report Number | 1016427-2020-03971 |
MDR Report Key | 9897988 |
Report Source | OTHER |
Date Received | 2020-03-30 |
Date of Report | 2020-03-30 |
Date of Event | 2020-03-04 |
Date Mfgr Received | 2020-03-05 |
Date Added to Maude | 2020-03-30 |
Event Key | 0 |
Report Source Code | Manufacturer report |
Manufacturer Link | Y |
Number of Patients in Event | 0 |
Adverse Event Flag | 3 |
Product Problem Flag | 3 |
Reprocessed and Reused Flag | 3 |
Health Professional | 3 |
Initial Report to FDA | 3 |
Report to FDA | 3 |
Event Location | 3 |
Manufacturer Contact | MRS. KARLA CASTRO |
Manufacturer Street | 14201 NW 60TH AVE |
Manufacturer City | MIAMI LAKES FL 33014 |
Manufacturer Country | US |
Manufacturer Postal | 33014 |
Manufacturer Phone | 7863138372 |
Manufacturer G1 | CORDIS CORPORATION |
Manufacturer Street | 14201 NW 60TH AVE |
Manufacturer City | MIAMI LAKES FL 33014 |
Manufacturer Country | US |
Manufacturer Postal Code | 33014 |
Single Use | 3 |
Previous Use Code | 3 |
Event Type | 3 |
Type of Report | 3 |
Brand Name | UNKNOWN TRAPEASE |
Generic Name | FILTER, INTRAVASCULAR, CARDIOVASCULAR |
Product Code | DTK |
Date Received | 2020-03-30 |
Catalog Number | 466P306X |
Lot Number | UNK |
Operator | HEALTH PROFESSIONAL |
Device Availability | N |
Device Eval'ed by Mfgr | N |
Device Sequence No | 1 |
Device Event Key | 0 |
Manufacturer | CORDIS CORPORATION |
Manufacturer Address | 14201 NW 60TH AVE MIAMI LAKES FL 33014 US 33014 |
Patient Number | Treatment | Outcome | Date |
---|---|---|---|
1 | 0 | 1. Life Threatening | 2020-03-30 |